市場調査レポート
商品コード
1408971

細胞透過性ペプチド（CPP）の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2024年～2032年）

Global Cell Penetrating Peptide Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
表紙：細胞透過性ペプチド（CPP）の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2024年～2032年）

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
カスタマイズ可能
細胞透過性ペプチド（CPP）の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2024年～2032年）
出版日: 2024年01月01日
発行: Value Market Research
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 図表
  • 目次
概要

世界の細胞透過性ペプチド（CPP）の市場規模は、2023年の21億7,000万米ドルから、2032年には57億7,000万米ドル近くに達し、調査期間2024年～2032年のCAGRは11.45%と推定されます。

細胞透過性ペプチド（CPP）は、細胞膜を通過する能力を持つ短いペプチド鎖であり、多様な分子の細胞内への輸送を助けます。研究やバイオテクノロジー、特にドラッグデリバリーで広く利用されているこれらのペプチドは、タンパク質、核酸、低分子などの様々なものを細胞内に輸送する上で極めて重要です。この能力は、無数の治療・診断用途に不可欠です。

市場力学

効率的なドラッグデリバリーシステム、特に標的治療に対する需要が、バイオテクノロジーと製薬研究におけるCPPの使用を後押ししています。バイオテクノロジーと分子生物学の絶え間ない進歩に伴い、CPPは治療分子を細胞内に送達し、治療効果を高める上で極めて重要です。製薬・バイオテクノロジー業界の研究開発投資の増加は、CPPを用いた革新的な治療戦略の探求にさらに拍車をかけています。がんや神経障害を含む慢性疾患の流行は、治療成績を向上させる手段としてCPPへの関心を高める一因となっています。技術の進歩や設計の最適化により、CPPの応用範囲は拡大し、効率も向上しています。さらに、研究機関、製薬会社、バイオテクノロジー企業間の共同研究や提携は、知識交換と技術革新を促進するCPP研究を加速させています。CPPの利点に対する認識が高まるにつれ、学術研究と製薬業界の両方での採用が増加し、細胞透過性ペプチド（CPP）市場全体の成長を牽引しています。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、細胞浸透性ペプチド（CPP）の世界市場における各セグメントを包括的に評価することもできます。細胞透過性ペプチド産業の成長と動向は、この研究に全体的なアプローチを提供します。

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカの地域展望をカバーし、細胞透過性ペプチド（CPP）市場の現在と将来の需要を明らかにしています。さらに、すべての主要地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

特注のご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 細胞透過性ペプチド（CPP）-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 細胞透過性ペプチド（CPP）の世界市場分析：タイプ別

  • タイプ別概要
  • 実績データと予測データ
  • タイプ別分析
  • タンパク質由来CPP
  • 合成CPP
  • キメラCPP

第6章 細胞透過性ペプチド（CPP）の世界市場分析：用途別

  • 用途別概要
  • 実績データと予測データ
  • 用途別分析
  • ドラッグデリバリー
  • 遺伝子デリバリー
  • 診断薬
  • 分子イメージング
  • その他

第7章 細胞透過性ペプチド（CPP）の世界市場分析：最終用途別

  • 最終用途別概要
  • 実績データと予測データ
  • 最終用途別分析
  • 製薬・バイオテクノロジー企業
  • 医薬品開発業務受託機関（CRO）
  • 病院・クリニック
  • その他

第8章 細胞透過性ペプチド（CPP）の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要・実績・予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要・実績・予測
    • 欧州セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要・実績・予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要・実績・予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要・実績・予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第9章 細胞透過性ペプチド（CPP）企業の競合情勢

  • 細胞透過性ペプチド市場競合
  • パートナーシップ／提携／協定
  • 合併・買収
  • 新製品上市
  • その他の開発

第10章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Pepscan
  • Creative Peptides
  • Cupidpeptides
  • AltaBioscience Ltd
  • AnaSpec
  • Peptomyc
  • BioAlps
  • Sarepta Therapeutics Inc.
  • REVANCE THERAPEUTICS
  • PolyPeptide Group
  • Bachem
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Protein-derived CPPs Market Sales by Geography (USD MN)
  • Synthetic CPPs Market Sales by Geography (USD MN)
  • Chimeric CPPs Market Sales by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Drug Delivery Market Sales by Geography (USD MN)
  • Gene Delivery Market Sales by Geography (USD MN)
  • Diagnostics Market Sales by Geography (USD MN)
  • Molecular Imaging Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End-use (USD MN)
  • Pharmaceutical And Biotechnology Companies Market Sales by Geography (USD MN)
  • Contract Research Organization (CROs) Market Sales by Geography (USD MN)
  • Hospitals And Clinics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Cell Penetrating Peptide Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cell Penetrating Peptide Report
  • Market Research Process
  • Market Research Methodology
  • Global Cell Penetrating Peptide Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Protein-derived CPPs Market Sales by Geography (USD MN)
  • Synthetic CPPs Market Sales by Geography (USD MN)
  • Chimeric CPPs Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Drug Delivery Market Sales by Geography (USD MN)
  • Gene Delivery Market Sales by Geography (USD MN)
  • Diagnostics Market Sales by Geography (USD MN)
  • Molecular Imaging Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Pharmaceutical And Biotechnology Companies Market Sales by Geography (USD MN)
  • Contract Research Organization (CROs) Market Sales by Geography (USD MN)
  • Hospitals And Clinics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112113285

The global demand for Cell Penetrating Peptide Market is presumed to reach the market size of nearly USD 5.77 BN by 2032 from USD 2.17 BN in 2023 with a CAGR of 11.45% under the study period 2024 - 2032.

Cell penetrating peptides (CPPs) are short peptide chains with the capability to traverse cell membranes, aiding in the conveyance of diverse molecules into cells. Widely utilized in research and biotechnology, especially for drug delivery, these peptides are pivotal in transporting various cargoes such as proteins, nucleic acids, and small molecules into cells. This ability is essential for a myriad of therapeutic and diagnostic applications.

MARKET DYNAMICS

The demand for efficient drug delivery systems, particularly for targeted therapies, has propelled the use of CPPs in biotechnology and pharmaceutical research. With continuous advancements in biotechnology and molecular biology, CPPs are crucial in delivering therapeutic molecules into cells, enhancing treatment efficacy. The pharmaceutical and biotech industry's increasing investment in research and development has further fueled the exploration of innovative treatment strategies using CPPs. The prevalence of chronic diseases, including cancer and neurological disorders, has contributed to the growing interest in CPPs as a means of improving treatment outcomes. Technological advancements and the optimization of its design have expanded their applications and enhanced efficiency. Additionally, collaborations and partnerships between research institutions, pharmaceutical companies, and biotech firms accelerate CPP research fostering knowledge exchange and innovation. As awareness of its benefits continues to rise, their adoption in both academic research and the pharmaceutical industry is increasing, driving the overall growth of the cell penetrating peptide market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell penetrating peptide. The growth and trends of cell penetrating peptide industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the cell penetrating peptide market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Protein-Derived Cpps
  • Synthetic Cpps
  • Chimeric Cpps

By Application

  • Drug Delivery
  • Gene Delivery
  • Diagnostics
  • Molecular Imaging
  • Others

By End-Use

  • Pharmaceutical And Biotechnology Companies
  • Contract Research Organization (Cros)
  • Hospitals And Clinics
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cell Penetrating Peptide market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Penetrating Peptide market include Pepscan, Creative Peptides, Cupidpeptides, AltaBioscience Ltd, AnaSpec, Peptomyc, BioAlps, Sarepta Therapeutics, Inc., REVANCE THERAPEUTICS, PolyPeptide Group, Bachem. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CELL PENETRATING PEPTIDE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CELL PENETRATING PEPTIDE MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Protein-derived CPPs Historic and Forecast Sales by Regions
  • 5.5 Synthetic CPPs Historic and Forecast Sales by Regions
  • 5.6 Chimeric CPPs Historic and Forecast Sales by Regions

6 . GLOBAL CELL PENETRATING PEPTIDE MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Drug Delivery Historic and Forecast Sales by Regions
  • 6.5 Gene Delivery Historic and Forecast Sales by Regions
  • 6.6 Diagnostics Historic and Forecast Sales by Regions
  • 6.7 Molecular Imaging Historic and Forecast Sales by Regions
  • 6.8 Others Historic and Forecast Sales by Regions

7 . GLOBAL CELL PENETRATING PEPTIDE MARKET ANALYSIS BY END-USE

  • 7.1 Overview by End-use
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-use
  • 7.4 Pharmaceutical And Biotechnology Companies Historic and Forecast Sales by Regions
  • 7.5 Contract Research Organization (CROs) Historic and Forecast Sales by Regions
  • 7.6 Hospitals And Clinics Historic and Forecast Sales by Regions
  • 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL CELL PENETRATING PEPTIDE MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE CELL PENETRATING PEPTIDE COMPANIES

  • 9.1. Cell Penetrating Peptide Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF CELL PENETRATING PEPTIDE INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Pepscan
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Creative Peptides
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Cupidpeptides
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. AltaBioscience Ltd
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. AnaSpec
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Peptomyc
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. BioAlps
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Sarepta Therapeutics Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. REVANCE THERAPEUTICS
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. PolyPeptide Group
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments
  • 10.13. Bachem
    • 10.13.1. Company Overview
    • 10.13.2. Company Revenue
    • 10.13.3. Products
    • 10.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies